Posterior cingulate hypoperfusion in Alzheimer's disease, senile dementia of Alzheimer type, and other dementias evaluated by three-dimensional stereotactic surface projections using Tc-99m HMPAO SPECT

Clinical Nuclear Medicine

Volumn 29, Issue 6, 2004, Pages 362-366

  Kaneko, Koichiro ^a   Kuwabara, Yasuo ^a   Sasaki, Masayuki ^a   Ogomori, Koji ^a   Ichimiya, Atsushi ^a   Koga, Hirofumi ^a   Nakagawa, Makoto ^a   Hayashi, Kazutaka ^a   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

3D SSP imaging; Alzheimer's disease; Posterior cingulate hypoperfusion; Senile dementia of Alzheimer type

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN PERFUSION; CINGULATE GYRUS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; INCIDENCE; MALE; NORMAL HUMAN; PERFUSION; SCORING SYSTEM; SENILE DEMENTIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; STEREOTAXIC SURGERY; THREE DIMENSIONAL IMAGING;

AGED; ALZHEIMER DISEASE; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DEMENTIA; FEMALE; GYRUS CINGULI; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 2442715145     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000127091.43180.92     Document Type: Article

References (24)

1. Minoshima S, Frey KA, Koappe RA, et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36:1238.
2. Minoshima S, Giordani B, Berent S, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 1997;42:85.
3. Burdette JH, Minoshima S, Vander Borght T, et al. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotactic surface projections. Radiology. 1996;198:837.
4. Friston KJ, Holmes AP, Worsley KJ, et al. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapping. 1995;2:189.
5. Kogure D, Matsuda H, Ohnishi T, et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med. 2000; 41:1155.
6. Mielke R, Herholz K, Grond M, et al. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiol Aging. 1992;13:93.
7. Ichimiya A, Herholz K, Mielke R, et al. Difference of regional metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study. J Neurol Sci. 1994;123:11.
8. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC. American Psychiatric Association; 1994:123-163.
9. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration a consensus on clinical diagnostic criteria. Neurology. 1998;51: 1546.
10. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985.
11. Mckeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113.
12. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189.
13. Anthony JC, LeResche L, Niaz U, et al. Limits of the 'Mini-Mental State' as a screening test for dementia and delirium among hospital patients. Psychol Med. 1982;12:397.
14. Lassen NA, Andersen AR, Friberg L, et al. The retention of [99mTc]-d,1-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab. 1988;6:S 13.
15. Hanyu H, Asano T, Kogure D, et al. Diagnosis of Alzheimer's disease using brain SPECT with three-dimensional stereotactic surface projections. Clin Neurol. 2001;41:582.
16. Pickut BA, Saerens J, Marien P, et al. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type. J Nucl Med. 1997;38:929.
17. 99mTc-HMPAO SPECT in the investigation of dementia? J Neurol Neurosurg Psychiatry. 1998;64:306.
18. 99mTc-HMPAO SPECT data. J Neurol Neurosurg Psychiatry. 2000;69:661.
19. 123I]Iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer's disease. Am J Psychiatry. 2002;159:474.
20. 99mTc-HMPAO single-photon emission computed tomography study of Lewy body disease. J Neurol. 1997;244:349.
21. Minoshima S, Foster NL, Sima AA, et al. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol. 2001;50:358.
22. Albin RL, Minoshima S, D'Amato CJ, et al. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology. 1996;47:462.
23. Small GW, Ercoli LM, Silverman DH, et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA. 2000;97:6037.
24. Lee YC, Liu RS, Liao YC, et al. Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer's disease. Eur Neurol. 2003;49:142.